Literature DB >> 15716153

Lack of inhibition in Parkinson's disease: evidence from a lexical decision task.

Paloma Marí-Beffa1, Amy E Hayes, Liana Machado, John V Hindle.   

Abstract

Persons affected by Parkinson's disease (PD) often show an increased semantic priming effect from target words in lexical decision tasks (hyper-priming) as compared to age-matched controls. In this study, a lexical decision task was used to investigate both semantic priming (Experiment 1) and repetition priming (Experiment 2) from distractor words in PD patients and age-matched controls. With this negative priming procedure, target words in successive trials are never related, and therefore participants always have to switch between unrelated target words. Instead, it is the distractor prime word that is either related or unrelated to the subsequent target, giving the measure of priming. Results showed that PD patients demonstrated a robust effect of positive semantic priming from distractor words. Participants from the control group did not show any semantic priming effect (positive or negative) from distractors. Similarly, PD patients showed positive repetition priming from distractor words, but the control group showed significant repetition negative priming. These results support the view that the hyper-priming effect typically shown by persons with Parkinson's disease is the result of impaired inhibitory processes required to control word activation during reading.

Entities:  

Mesh:

Year:  2005        PMID: 15716153     DOI: 10.1016/j.neuropsychologia.2004.07.006

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  12 in total

Review 1.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

2.  Impaired inhibitory oculomotor control in patients with Parkinson's disease.

Authors:  Prakash Joti; Shrikanth Kulashekhar; Madhuri Behari; Aditya Murthy
Journal:  Exp Brain Res       Date:  2006-09-19       Impact factor: 1.972

3.  Space-based but not object-based inhibition of return is impaired in Parkinson's disease.

Authors:  Katherine L Possin; J Vincent Filoteo; David D Song; David P Salmon
Journal:  Neuropsychologia       Date:  2009-02-11       Impact factor: 3.139

4.  Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease.

Authors:  Elmar H Pinkhardt; Jan Kassubek; Sigurd Süssmuth; Albert C Ludolph; Wolfgang Becker; Reinhart Jürgens
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

5.  Altered Inhibitory Mechanisms in Parkinson's Disease: Evidence From Lexical Decision and Simple Reaction Time Tasks.

Authors:  Alban Letanneux; Jean-Luc Velay; François Viallet; Serge Pinto
Journal:  Front Hum Neurosci       Date:  2021-04-26       Impact factor: 3.169

6.  Intact encoding, impaired consolidation in procedural learning in Parkinson's disease.

Authors:  Henri Cohen; Emmanuelle Pourcher
Journal:  Exp Brain Res       Date:  2007-02-06       Impact factor: 2.064

7.  Famous faces demand attention due to reduced inhibitory processing.

Authors:  Liana Machado; Hayley Guiney; Andrew Mitchell
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

8.  Lexical ambiguity resolution during sentence processing in Parkinson's disease: An event-related potential study.

Authors:  Anthony J Angwin; Nadeeka N W Dissanayaka; Katie L McMahon; Peter A Silburn; David A Copland
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

9.  The Suppression of Irrelevant Semantic Representations in Parkinson's Disease.

Authors:  Megan L Isaacs; Katie L McMahon; Anthony J Angwin; David A Copland
Journal:  Front Hum Neurosci       Date:  2019-01-22       Impact factor: 3.169

10.  Evidence inhibition responds reactively to the salience of distracting information during focused attention.

Authors:  Natalie Wyatt; Liana Machado
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.